Found 12 matching trials
A New Treatment Option for Heavy Menstrual Bleeding
PHASE4Women with measured menstrual bleeding \>80ml per cycle and no contraindica...
Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS
PHASE2This is a Phase II, open-label clinical trial examining the role of Panhema...
Location
Rush University Medical Center
Acute Porphyria Biomarkers for Disease Activity
N/AThe long term objective of the research is to identify new biomarkers of di...
Status
Active Not Recruiting
Location
University of Texas Medical Branch
A Prospective Pilot Study to Evaluate the Diagnostic Performance of a Wireless Sensor Capsule in Detection of UGIB
NAIt is a single-center, prospective study, which will be conducted in a tert...
Location
Prince of Wales Hospital
Hemin to Prevent Post-ERCP (Endoscopic Retrograde Cholangiopancreatography) Acute Pancreatitis
PHASE2ERCP (endoscopic retrograde cholangiopancreatography) has been largely demo...
Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria
PHASE2This study aims to provide high quality evidence for the effectiveness and ...
Location
University of Texas Medical Branch
Measuring Menstrual Iron Loss Using the Iron Isotope Dilution Technique
N/AIt is very difficult to quantify menstrual blood loss, the reference method...
Reframing Endometrial Physiology by Advanced Integrated Research
N/AHeavy menstrual bleeding (HMB) affects 1 in 3 women and can significantly i...
Location
University Hospital Southampton
Panhematin for Prevention of Acute Attacks of Porphyria
PHASE2The purpose of this study is to determine if Panhematin is safe and effecti...
Location
University of Texas Medical Branch
Induction of HO-1; a Therapeutic Approach to Reduce Ischaemia Reperfusion Injury (IRI) Following Deceased Donor Renal Transplantation
PHASE3This is a blinded, placebo-controlled, randomised controlled trial looking ...
Location
Royal Infirmary of Edinburgh/ University of Edinburgh